Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 6:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 3,242 | $15.25 | $49,434 | 123,736 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:30 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 5,313 | $11.69 | $62,109 | 67,978 (Direct) | View |
| 2021-07-30 Sale | 2021-08-03 4:56 pm | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 2,466 | $67.9 | $167,441 | 14,749 (Indirect Direct) | View |
| 2021-05-05 Sale | 2021-05-07 4:57 pm | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 3,119 | $64.21 | $200,271 | 17,208 (Indirect Direct) | View |
| 2020-11-24 Sale | 2020-11-25 4:32 pm | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 900 | $63.39 | $57,051 | 16,137 (Indirect Direct) | View |
| 2020-05-22 Sale | 2020-05-26 5:17 pm | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 3,200 | $61.01 | $195,232 | 17,023 (Indirect Direct) | View |
| 2019-12-05 Sale | 2019-12-09 4:44 pm | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam Chief Compliance & Ethics Offi | 1,740 | $58.81 | $102,329 | 16,674 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Exercise | 2024-02-20 6:48 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 8,399 | $0 | 123,736 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:25 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 149,000 | $0 | 149,000 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:30 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 13,600 | $0 | 67,978 (Direct) | View |
Ownership | 2023-11-16 8:39 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 0 | $0 | 472,291 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 6:59 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 1,910 | $60.93 | 36,512 (Direct) | View |
| 2021-03-10 Other | 2021-03-12 6:59 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 754 | $0 | 36,512 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 6:59 pm | N/A 2021-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 5,404 | $0 | 36,512 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:59 pm | N/A 2025-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 9,953 | $0 | 36,512 (Direct) | View |
| 2020-03-10 Other | 2020-03-12 6:12 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 587 | $0 | 35,081 (Direct) | View |
| 2020-03-10 Exercise | 2020-03-12 6:12 pm | N/A 2020-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 5,007 | $0 | 35,081 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 6:12 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 9,808 | $0 | 35,081 (Direct) | View |
| 2020-03-10 Tax Withholding | 2020-03-12 6:12 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. | 2,005 | $57.93 | 35,081 (Direct) | View |